Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
May 30, 2019
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
Silvia La Monica, Roberta Minari, Daniele Cretella, et al.
Cells
|
July 2, 2021
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells
Valentina Coccè, Silvia La Monica, Mara Bonelli, et al.
Neoplasia (New York, N.Y.)
|
July 14, 2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells
Mara A Bonelli, Graziana Digiacomo, Claudia Fumarola, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
October 15, 2014
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†
Luca Ampollini, Denise Madeddu, Angela Falco, et al.
Oncotarget
|
September 9, 2017
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN
Andrea Cavazzoni, Silvia La Monica, Roberta Alfieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2017
Low PD-1 Expression in Cytotoxic CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value
Giulia Mazzaschi, Denise Madeddu, Angela Falco, et al.
Plos One
|
November 17, 2015
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method
Cecilia Bozzetti, Federico Quaini, Anna Squadrilli, et al.
Cancer Research Communications
|
April 18, 2025
Correction: Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Cancer Research Communications
|
March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Nature Medicine
|
April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome
Raffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Journal of Experimental & Clinical Cancer Research : CR
|
May 30, 2019
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
Silvia La Monica, Roberta Minari, Daniele Cretella, et al.
Cells
|
July 2, 2021
Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells
Valentina Coccè, Silvia La Monica, Mara Bonelli, et al.
Neoplasia (New York, N.Y.)
|
July 14, 2017
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells
Mara A Bonelli, Graziana Digiacomo, Claudia Fumarola, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
October 15, 2014
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†
Luca Ampollini, Denise Madeddu, Angela Falco, et al.
Oncotarget
|
September 9, 2017
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN
Andrea Cavazzoni, Silvia La Monica, Roberta Alfieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 2017
Low PD-1 Expression in Cytotoxic CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value
Giulia Mazzaschi, Denise Madeddu, Angela Falco, et al.
Plos One
|
November 17, 2015
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method
Cecilia Bozzetti, Federico Quaini, Anna Squadrilli, et al.
Cancer Research Communications
|
April 18, 2025
Correction: Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Cancer Research Communications
|
March 28, 2024
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, et al.
Nature Medicine
|
April 8, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome
Raffaella Molteni, Martina Fiumara, Corrado Campochiaro, et al.
Page
of 10